Literature DB >> 32467880

Macrophages enhance 3D invasion in a breast cancer cell line by induction of tumor cell tunneling nanotubes.

Kiersten P Carter1, Samer Hanna1, Alessandro Genna1, Daniel Lewis2, Jeffrey E Segall1,3, Dianne Cox1,3,4.   

Abstract

Background: Metastasis is the cause of most cancer-related deaths. It is known that breast cancer cells in proximity to macrophages become more invasive in an Epidermal Growth Factor (EGF) dependent manner. Tunneling nanotubes (TNTs) are thin, F-actin containing, cellular protrusions that mediate intercellular communication and have been identified in many tumors. The mechanism of TNT formation varies between different cell types. M-Sec (TNFAIP2) has been demonstrated to be involved in TNT formation in some cell types including macrophages. Yet, the requirement of M-Sec in tumor cell TNT formation in response to macrophages has not been explored. Aim: The aim of this study was to determine whether EGF was required for macrophage induced tumor cell TNTs in an M-Sec dependent manner and what possible roles tumor cell TNTs play in tumor cell migration and invasion. Methods and
Results: Macrophage Conditioned Media (CM) was used to induce an increase in TNTs in a number of breast cancer cell lines as measured by live cell microscopy. Tumor cell TNT formation by CM was dependent on the presence of EGF which was sufficient to induce TNT formation. CM treatment enhanced the level of M-Sec identified using western blot analysis. Reduction of endogenous M-Sec levels via shRNA in MTLn3 mammary adenocarcinoma cells inhibited the formation of TNTs. The role of tumor cell TNTs in cell behavior was tested using in vitro transwell and 3D invasion assays. No effect on chemotaxis was detected but 3D invasion was reduced following the knockdown of M-Sec in tumor cell TNTs. Conclusions: Our results show that EGF was necessary and sufficient for tumor cell TNT formation which was dependent on cellular M-Sec levels. While tumor cell TNTs may not play a role in individual cell behaviors like chemotaxis, they may be important in more complex tumor cell behaviors such as 3D invasion.

Entities:  

Keywords:  Breast cancer; Invasion; Macrophage; Tumor cells; Tunneling Nanotubes

Year:  2019        PMID: 32467880      PMCID: PMC7254960          DOI: 10.1002/cnr2.1213

Source DB:  PubMed          Journal:  Cancer Rep (Hoboken)        ISSN: 2573-8348


  37 in total

1.  Nanotubular highways for intercellular organelle transport.

Authors:  Amin Rustom; Rainer Saffrich; Ivanka Markovic; Paul Walther; Hans-Hermann Gerdes
Journal:  Science       Date:  2004-02-13       Impact factor: 47.728

2.  Functional connectivity between immune cells mediated by tunneling nanotubules.

Authors:  Simon C Watkins; Russell D Salter
Journal:  Immunity       Date:  2005-09       Impact factor: 31.745

Review 3.  Dynamic properties of antigen uptake and communication between dendritic cells.

Authors:  Russell D Salter; Simon C Watkins
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

4.  KLF5 promotes breast cancer proliferation, migration and invasion in part by upregulating the transcription of TNFAIP2.

Authors:  L Jia; Z Zhou; H Liang; J Wu; P Shi; F Li; Z Wang; C Wang; W Chen; H Zhang; Y Wang; R Liu; J Feng; C Chen
Journal:  Oncogene       Date:  2015-07-20       Impact factor: 9.867

5.  A novel role for TNFAIP2: its correlation with invasion and metastasis in nasopharyngeal carcinoma.

Authors:  Lih-Chyang Chen; Chia-Chun Chen; Ying Liang; Ngan-Ming Tsang; Yu-Sun Chang; Chuen Hsueh
Journal:  Mod Pathol       Date:  2010-11-05       Impact factor: 7.842

6.  EGF stimulates lamellipod extension in metastatic mammary adenocarcinoma cells by an actin-dependent mechanism.

Authors:  J E Segall; S Tyerech; L Boselli; S Masseling; J Helft; A Chan; J Jones; J Condeelis
Journal:  Clin Exp Metastasis       Date:  1996-01       Impact factor: 5.150

7.  Downregulation of TNFAIP2 suppresses proliferation and metastasis in esophageal squamous cell carcinoma through activation of the Wnt/β-catenin signaling pathway.

Authors:  Yunbo Xie; Bin Wang
Journal:  Oncol Rep       Date:  2017-04-05       Impact factor: 3.906

8.  MicroRNA-184 inhibits cell proliferation and invasion, and specifically targets TNFAIP2 in Glioma.

Authors:  Zhe Cheng; Hang Zhou Wang; Xuetao Li; Zhiwu Wu; Yong Han; Yanyan Li; Guilin Chen; Xueshun Xie; Yulun Huang; Ziwei Du; Youxin Zhou
Journal:  J Exp Clin Cancer Res       Date:  2015-03-26

9.  Cancer testis antigen Sperm Protein 17 as a new target for triple negative breast cancer immunotherapy.

Authors:  Leonardo Mirandola; Elisa Pedretti; Jose A Figueroa; Raffaella Chiaramonte; Michela Colombo; Caroline Chapman; Fabio Grizzi; Federica Patrinicola; W Martin Kast; Diane D Nguyen; Rakhshanda Layeequr Rahman; Naval Daver; Peter Ruvolo; Sean M Post; Robert S Bresalier; Maurizio Chiriva-Internati
Journal:  Oncotarget       Date:  2017-08-10

Review 10.  The roles of TNFAIP2 in cancers and infectious diseases.

Authors:  Lin Jia; Yundong Shi; Yi Wen; Wei Li; Jing Feng; Ceshi Chen
Journal:  J Cell Mol Med       Date:  2018-08-25       Impact factor: 5.310

View more
  4 in total

1.  Microscopic Methods for Analysis of Macrophage-Induced Tunneling Nanotubes.

Authors:  Kiersten P Carter; Jeffrey E Segall; Dianne Cox
Journal:  Methods Mol Biol       Date:  2020

2.  Effects of the media conditioned by various macrophage subtypes derived from THP-1 cells on tunneling nanotube formation in pancreatic cancer cells.

Authors:  Chia-Wei Lee; Chia-Chen Kuo; Chi-Jung Liang; Huei-Jyuan Pan; Chia-Ning Shen; Chau-Hwang Lee
Journal:  BMC Mol Cell Biol       Date:  2022-07-06

3.  Macrophages enhance 3D invasion in a breast cancer cell line by induction of tumor cell tunneling nanotubes.

Authors:  Kiersten P Carter; Samer Hanna; Alessandro Genna; Daniel Lewis; Jeffrey E Segall; Dianne Cox
Journal:  Cancer Rep (Hoboken)       Date:  2019-08-28

Review 4.  Beyond Neurons: Long Distance Communication in Development and Cancer.

Authors:  Patrick McMillen; Madeleine J Oudin; Michael Levin; Samantha L Payne
Journal:  Front Cell Dev Biol       Date:  2021-09-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.